Pancreatic Atrophy in Rats Produced by the Cholecystokinin-A Receptor Antagonist Devazepide

References

• Håkanson R, Axelson J, Ihse I, Sundler F. The targets for the trophic action of gastrin and cholecystokinin. The stomach as an endocrine organ. Fernstrom Symposium no. 15., R Håkanson, F Sundler. Elsevier, Amsterdam 1991; 307–20
   Google Scholar
• Anderson PS, Freidinger RM, Evans BE, . Design of nonpeptide antagonists of cholecystokinin from the natural product asperlicin. Gastrin and cholecystokinin. Chemistry, physiology and pharmacology. Excerpta Medica, International Congress Series 766, J-P Bali, J Martinez, et al. Elsevier, Amsterdam 1987; 235–42
   Google Scholar
• Freidinger RM. Cholecystokinin and gastrin antagonists. Med Res Rev 1989; 9: 271–90
   PubMed Web of Science ®Google Scholar
• Williams JA, Hallden G, McChesney D, Szecowka J, Logsdon CD, Goldfine JD. The cholecystokinin and gastrin receptors. Neuropeptides and their receptors. Alfred Benzon Symposium no. 29., TW Schwartz, LM Hilsted, JF Rehfeld. Munksgaard, Copenhagen 1990; 310–9
   Google Scholar
• Woodruff GN, Hughes J. Cholecystokinin antagonists. Ann Rev Pharmacol Toxicol 1991; 31: 469–501
   PubMed Web of Science ®Google Scholar
• Schmidt WE, Roy Choudhury A, Siegel E, Wilms HM, Folsch UR, Creutzfeldt W. CCK-antagonist L-364,718: influence on caerulein- and bombesin-induced growth of the rat pancreas [abstract]. Dig Dis Sci 1987; 32: 1188
   Google Scholar
• Schmidt WE, Roy Choudhury A, Siegel EG, et al. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides. Regul Pept 1989; 24: 67–79
   PubMedGoogle Scholar
• Zucker KA, Adrian TE, Bilchik A, Modlin IM. Is cholecystokinin responsible for normal pancreatic growth?. Gastroenterology 1988; 94: 518, abstract
   Google Scholar
• Zucker KA, Adrian TE, Bilchik A, Modlin IM. Effects of the receptor antagonist L-364,718 on pancreatic growth in adult and developing animals. Am J Physiol 1989; 257: G511–6
   PubMedGoogle Scholar
• Wisner JR, Ozawa S, Xue BG, Renner IG. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats. Pancreas 1990; 5: 434–8
   PubMed Web of Science ®Google Scholar
• Rivard N, Guan D, Maouyo D, Grondin B, Berube FL, Morisset J. Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion. Endocrinology 1991; 129: 2867–74
   PubMedGoogle Scholar
• Axelson J, Hakanson R, Ihse I, Lilja I, Rehfeld JF, Sundler F. Effects of endogenous and exogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth. Scand J Gastroenterol 1990; 25: 471–80
   PubMed Web of Science ®Google Scholar
• Gasslander T, Axelson J, H&kanson R, et al. Cholecystokinin is responsible for growth of the pancreas following pancre-aticobiliary diversion in rats. Scand J Gastroenterol 1990; 25: 1060–5
   PubMed Web of Science ®Google Scholar
• Dowling RH, Hosomi M, Stace NH, et al. Hormones and polyamines in intestinal and pancreatic adaptation. Scand J Gastroenterol 1985; 20: 84–95, Suppl 112
   Web of Science ®Google Scholar
• Rehfeld JF. Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontatriapeptide cholecystokinin. J Biol Chem 1978; 253: 4016–21
   PubMed Web of Science ®Google Scholar
• Cantor P. Evaluation of a radioimmunoassay for cholecystokinin in human plasma. Scand J Clin Lab Invest 1986; 26: 213–21
   Google Scholar
• Labarca C, Paigen K. A simple, rapid and sensitive DNA assay mixture. Anal Biochem 1980; 102: 344–52
   PubMed Web of Science ®Google Scholar
• Lotti VJ, Pendleton RG, Gould RJ, Hanson HM, Chang RSL, Clineschmidt BV. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. J Pharmacol Exp Ther 1987; 241: 103–9
   PubMed Web of Science ®Google Scholar
• Rothman SS, Wells H. Enhancement of pancreatic enzyme synthesis by pancreozymin. Am J Physiol 1967; 213: 215–20
   PubMed Web of Science ®Google Scholar
• Borrowman JA, Mayston PD. The trophic influence of CCK-PZ on the rat pancreas. J Physiol (Lond) 1973; 238: 73–5
   Google Scholar
• Mainz DL, Black O, Webster PO. Hormonal control of pancreatic growth. J Clin Invest 1973; 52: 2300–4
   PubMed Web of Science ®Google Scholar
• Ihse I, Arnesjo B, Lundquist I. Effects on exocrine and endocrine rat pancreas of long-term administration of CCK-PZ (cholecystokinin-pancreozymin) or synthetic octapeptide-CCK-PZ. Scand J Gastroenterol 1976; 11: 529–35
   PubMed Web of Science ®Google Scholar
• Fölsch UR, Winckler K, Wormsley KG. Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. Scand J Gastroenterol 1978; 13: 663–71
   PubMed Web of Science ®Google Scholar
• Solomon TE, Petersen H, Elashoff J, Grossman MI. Interaction of caerulein and secretin on pancreatic size and composition in rat. Am J Physiol 1978; 235: E714–9
   PubMedGoogle Scholar
• Solomon TE, Vanier M, Morisset J. Cell site and time course of DNA synthesis in pancreas after caerulein and secretin. Am J Physiol 1983; 245: G99–105
   PubMedGoogle Scholar
• Arnesjö B, Ihse I, Lundquist I, Quist L. Effects of exocrine rat pancreatic functions of bovine lung trypsin inhibitor administered perorally. Scand J Gastroenterol 1973; 8: 544–54
   Web of Science ®Google Scholar
• Folsch UR, Winckler K, Wormsley KG. Effect of a soybean diet on enzyme content and ultrastructure of the rat exocrine pancreas. Digestion 1974; 11: 161–71
   PubMed Web of Science ®Google Scholar
• Ihse 1, Arnesjö B, Lundquist I. Studies on the reversibility of oral trypsin inhibitor induced changes of rat pancreatic enzyme activity and insulin secretory capacity. Scand J Gastroenterol 1975; 10: 321–6
   PubMed Web of Science ®Google Scholar
• Yonezawa H. Secretory responses of hypertrophied rat pancreas induced by repeated oral administration of a synthetic protease inhibitor. Jpn J Physiol 1983; 33: 183–95
   PubMedGoogle Scholar
• Fölsch UR. Regulation of pancreatic growth. Clin Gastroenterol 1984; 13: 679–99
   PubMedGoogle Scholar
• Liddle RA, Goldfine ID, Williams J. A. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 1984; 87: 542–9
   PubMed Web of Science ®Google Scholar
• Göke B, Printz H, Koop I, et al. Endogenous CCK release and pancreatic growth after feeding a proteinase inhibitor (Camo-state). Pancreas 1986; 1: 509–15
   PubMedGoogle Scholar
• Owyang C, May D, Louie DS. Trypsin suppression of pancreatic enzyme secretion. Gastroenterology 1986; 91: 637–43
   PubMedGoogle Scholar
• Niederau C, Liddle RA, Williams JA, Grendell JH. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice. Gut 1987; 28(Sl)63–9
   PubMedGoogle Scholar
• Miazza BM, van Hung L, Vaja S, Dowling RH. Pancreatic hyperplasia after pancreatico-biliary diversion (PBD) in orally-and parenterally fed rats. Mechanisms of intestinal adaptation, JWL Robinson, R Dowling, E-O Riecken. MTP Press Ltd., Lancaster 1981; 481–90
   Google Scholar
• Miazza BM, Turberg Y, Guillaume P, Hahne W, Chayvialle JA, Loizeau E. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Scand J Gastroenterol 1985; 20: 75–83, Suppl 112
   Web of Science ®Google Scholar
• Miazza BM, Windgren S, Chayvialle JA, Nicolet T, Loizeau E. Exocrine pancreatic nodules after long-term pancreaticobiliary diversion in rats. An effect of raised CCK plasma concentrations. Gut 1987; 28: 269–73
   PubMed Web of Science ®Google Scholar
• Holmberg JT, Ihse I. Influence of bile duct occlusion on the exocrine pancreas in rats. Scand J Gastroenterol 1985; 20: 1065–72
   PubMed Web of Science ®Google Scholar
• Shiratori K, Chen YF, Chey WY, Lee KY, Chang T-M. Mechanism of increased exocrine pancreatic secretion in pancreatic juice-diverted rats. Gastroenterology 1986; 91: 1171–8
   PubMed Web of Science ®Google Scholar
• Levan VH, Liddle RA, Green GM. Jejunal bypass stimulation of pancreatic growth and cholecystokinin secretion in rats: importance of luminal nutrients. Gut 1987; 28(Sl)25–9
   PubMedGoogle Scholar
• Kashima K, Sato T, Herman L. Morphometric study of the rat exocrine pancreas after diversion of bile and pancreatic juice from the intestines. Gastroenterology 1988; 95: 1607–16
   PubMedGoogle Scholar
• Yamaguchi T, Tabata K, Johnson LR. Effect of proglumide on rat pancreatic growth. Am J Physiol 1985; 249: G294–8
   PubMedGoogle Scholar
• Damge G, Hajiri A, Aprahamian M. Effects of a new potent CCK receptor antagonist on the trophic action of CCK, caeru-lein, bombesin and GRP on the rat exocrine pancreas [abstract]. Digestion 1987; 38: 12
   Google Scholar
• Wisner JR, McLaughlin RE, Rich KA, Ozawa S, Renner IG. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas. Gastroenterology 1988; 94: 109–13
   PubMed Web of Science ®Google Scholar
• Berlin RG. MK-329 has no direct effect on the pancreas [letter]. Gastroenterology 1989; 97: 553–4
   PubMedGoogle Scholar